The 2004 Legislative Session was the most intense I have dealt with. Thanks to Mike Walker and Dominic Silva for the work with NMPhA during this session!

Major issues were concerned with the state’s budget and the impact on provider funding.

Two major bills were stopped.

Legislation to change statutory provisions relating to pharmacy reimbursement were introduced during this session.

Senate Bill 183, was withdrawn at the request of the sponsor, Senator Linda Lopez.

House Bill 406, was place on the table in House Business and Industry Committee. The sponsor, James G. Taylor, agreed with Committee Chairman Fred Luna, that placing the bill on the table was appropriate.

Thanks to the Legislators for their help in
keeping these bills from passing! 

Thanks Senator Lopez, Senator Michael Sanchez and others for their support!

Thanks to Representative James G. Taylor and to Representative Fred Luna and the House Business and Industries Committee.

The Following Legislation was passed
and signed by the Governor.

Bill: HB88

Sponsors: Picraux

Title: 340B FEDERAL DRUG PRICING PROGRAM

Analysis: Introduced 01/21/2004 — In an effort to reduce the cost of prescription drugs for Medicaid recipients, the Human Services Department is required to carry out program changes to ensure that all eligible entities participate in the 340B federal drug pricing program.

HCPAC Committee Substitute 01/30/2004 — HCPAC substitute for HB88 is identical to SB264, which requires that all programs, clinics, hospitals and other healthrelated centers and entities that are eligible under Sec. 340B of the federal Public Health Services Act shall participate in the Sec. 340B federal prescription drug price discount program. An exception will be granted to any entity that can demonstrate that it receives another prescription drug price discount that results in greater savings to the state than would be available through the 340B program.

Status: 03/03/2004 – Signed by the Governor

 

Bill: HB254

Sponsors: Beam

Title: IMMUNIZATION ACT

Analysis: Introduced 01/26/2004 — (Identical to SB203) Creates the Immunization Act, requiring the Department of Health, in conjunction with the Human Services Department, to establish and maintain a state immunization registry.
Immunization information is to be reported to the registry by health care providers unless the patient refuses to allow reporting of the information. Access to the registry is limited to primary care physicians, nurses, school nurses and other appropriate health care providers.

HCPAC Committee Report 02/06/2004 — HCPAC amendment to HB254 makes reporting by health care providers to the Immunization Registry optional rather than mandatory. Adds protection from liability for persons using immunization information as authorized by the Immunization Act.

House Floor Amendment 02/09/2004 — House floor amendment to HB254 allows a managed care organization to have access to information in the Immunization Registry, but only for its enrollees.

Status: 03/03/2004 – Signed by the Governor

 

Bill: HB581

Sponsors: Picraux

Title: NEW MEXICO TELEHEALTH ACT

Analysis: HCPAC Committee Substitute 02/11/2004 — HCPAC substitute for HB581 (replaces a dummy bill) creates the New Mexico Telehealth Act to provide a framework for health care providers to follow in providing telehealth to New Mexico citizens. Telehealth is the use of electronic information, imaging and communication technologies to provide health care services when distance separates the patient and the health care provider.
The act recognizes and strongly encourages the delivery of health care via telehealth; and provides that no health care provider shall be disciplined for or discouraged from participating in telehealth pursuant to the New Mexico Telehealth Act; but does not require inclusion of telehealth in the plan or policy offered by any health insurer, HMO, managed care organization, provider service organization or the state’s medical assistance program.

Status: 03/03/2004 – Signed by the Governor

 

Bill: SB34

Sponsors: Lopez; Komadina

Title: COMPREHENSIVE STRATEGIC HEALTH PLAN

Analysis: Introduced 01/20/2004 — (For the Legislative Health and Human Services Committee) Directs the Department of Health, with the Health Policy Commission and other state agencies, to develop and publish by July 1, 2004 (and July 1 of subsequent evennumbered years) a comprehensive strategic plan for health that emphasizes prevention, personal responsibility, access and quality.

SPAC Committee Report 01/31/2004 — SPAC amendment to SB34 requires that the Department of Health include pharmaceutical manufacturers, managed care organizations, major insurers, the Human Services Department, the Children, Youth and Families Department and the State Agency on Aging in its development of a comprehensive strategic plan for health. Among the areas to be addressed in the plan, special attention is called to the disparities that currently exist for different population groups; a continuum of care model is expanded to include public health and emergency medical services; and planning and response to public health emergencies is added.

Status: 03/03/2004 – Signed by the Governor

 

Bill: SB536

Sponsors: Papen

Title: PRESCRIPTION DRUG PROGRAMS AND FEES

Analysis: Introduced 02/04/2004 — Amends the Pharmacy Act to require a license, with an annual fee of up to $5,000, for a wholesale drug distributor, nonresident pharmacy, drug manufacturer or drug warehouse. The license fee shall not exceed $1,000 if Title 18 of the federal Social Security Act provides a prescription drug program for seniors.
Requires that a pharmaceutical sales representative who carries dangerous drugs shall provide the Pharmacy Board with a written statement from his employer that describes the employers’ safety and security policy and compliance with the federal Prescription Drug Marketing Act of 1987.
Provides that of amounts paid into the Pharmacy Fund for license fees, 50 percent shall be used for a prescription drug program for seniors; 40 percent shall be used for a prescription drug program for lowincome persons; and 10 percent shall remain available to meet the administrative and enforcement expenses of the Pharmacy Board.

SPAC Committee Report 02/11/2004 — SPAC amendment to SB536 reduces license fee from $5,000 to $4,000 and provides that it would not exceed $1,000 upon implementation of a Medicare prescription drug program under the act passed by Congress last year. Instead of the 504010 percent split of the Pharmacy Fund in the bill, the amendment provides that 15 percent would be spent for enforcement and administration of the Pharmacy Act, 65 percent for a drug program for those over age 65, and 20 percent for a drug program for lowincome persons. Bill now moves to SFC.

SFC Committee Report 02/13/2004 — SFC substitute for SB536 removes nonresident pharmacies from the list of entities required to pay the new fee and reinstates the $5,000 maximum. Simplifies provision for use of the new fees by providing that all amounts shall be used for a seniors’ prescription dug program.
As substituted the bill amends the Pharmacy Act to require a license, with an annual fee of up to $5,000, for a wholesale drug distributor, drug manufacturer or drug warehouse. The license fee shall not exceed $1,000 upon implementation of a Medicare prescription drug program under the act passed by Congress last year. Amounts paid into the Pharmacy Fund shall be used for a prescription drug program for persons over the age of 65.
Requires that a pharmaceutical sales representative who carries dangerous drugs shall provide the Pharmacy Board with a written statement from his employer that describes the employers’ safety and security policy and compliance with the federal Prescription Drug Marketing Act of 1987.

SFC Committee Substitute 02/13/2004 — SFC substitute for SB536 removes nonresident pharmacies from the list of entities required to pay the new fee and reinstates the $5,000 maximum. Simplifies provision for use of the new fees by providing that all amounts shall be used for a seniors’ prescription dug program.
As substituted the bill amends the Pharmacy Act to require a license, with an annual fee of up to $5,000, for a wholesale drug distributor, drug manufacturer or drug warehouse. The license fee shall not exceed $1,000 upon implementation of a Medicare prescription drug program under the act passed by Congress last year. Amounts paid into the Pharmacy Fund shall be used for a prescription drug program for persons over the age of 65.
Requires that a pharmaceutical sales representative who carries dangerous drugs shall provide the Pharmacy Board with a written statement from his employer that describes the employers’ safety and security policy and compliance with the federal Prescription Drug Marketing Act of 1987.

Status: 03/03/2004 – Signed by the Governor